{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T03:21:42Z","timestamp":1775791302556,"version":"3.50.1"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma is a rare extranodal B-cell lymphoma, representing the most common primary pulmonary lymphoma (&amp;lt; 0.5% of all lung malignancies). Diagnosis is difficult because of its nonspecific clinical and radiological characteristics, which often resemble infections, inflammatory diseases, or other malignancies. Typical imaging findings include nodules, consolidations, or, less frequently, interstitial patterns such as ground-glass opacities. A conclusive diagnosis requires histological examination, augmented by immunohistochemistry and molecular investigations, to confirm clonality. Conventional biopsies may yield inconclusive outcomes due to small sample size and delicate cytologic atypia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      A 36-year-old non-smoking Asian female with no history of pulmonary tuberculosis, malignancies, or autoimmune disorders was incidentally found to have patchy opacities in the left lower lobe on routine chest radiography in January 2024. She remained asymptomatic over the 18-month disease progression period, lacking respiratory or systemic symptoms, whereas follow-up imaging indicated progression to bilateral, multifocal flocculent opacities. Initial investigations, including transbronchial forceps biopsy and bronchoalveolar lavage fluid analysis through next-generation sequencing, reported only non-specific chronic inflammation and no pathogens. Empirical treatment with moxifloxacin (400\u202fmg daily for 14\u202fdays), targeting common pathogens of community-acquired pneumonia, yielded no improvement. A definitive diagnosis was achieved by endobronchial ultrasound-guided transbronchial cryobiopsy (EBUS-TBCB), which produced larger, well-preserved tissue specimens. Histopathological and immunohistochemical examination indicated a dense, angiocentric infiltration of CD20-positive B cells, accompanied by monoclonal rearrangement of immunoglobulin genes, confirming extranodal marginal zone lymphoma of the MALT type. Staging with\n                      <jats:sup>68<\/jats:sup>\n                      Ga-CXCR4 positron emission tomography (PET)\/computed tomography (CT) demonstrated hypermetabolism in bilateral pulmonary opacities and multiple nodal stations, indicative of stage IV disease. Considering the asymptomatic status and excellent performance status, active surveillance was recommended in this patient.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This case illustrates the important role of advanced biopsy techniques, such as EBUS-TBCB, in acquiring sufficient tissue for diagnosing pulmonary MALT lymphoma when conventional methods fail. It further underscores the\n                      <jats:sup>68<\/jats:sup>\n                      Ga-CXCR4-targeted PET\/CT for precise staging. Despite the advanced stage, the indolent nature of MALT lymphoma often allows for a plan of active surveillance in selected asymptomatic patients, emphasizing the crucial role of a multidisciplinary, risk-adapted strategy.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1719542","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T06:45:07Z","timestamp":1766040307000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic challenges and management strategies of pulmonary mucosa-associated lymphoid tissue lymphoma: a case report and literature review"],"prefix":"10.3389","volume":"12","author":[{"given":"Jian","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bijun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1097\/00000478-200108000-00003","article-title":"Pathologic and clinical features of primary pulmonary extranodal marginal zone B-cell lymphoma of MALT type","volume":"25","author":"Kurtin","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1183\/09031936.00039309","article-title":"Clinical characteristics and prognostic factors of pulmonary MALT lymphoma","volume":"34","author":"Borie","year":"2009","journal-title":"Eur Respir J"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.lungcan.2019.04.004","article-title":"Clinical features and outcomes of pulmonary lymphoma: a single center experience of 180 cases","volume":"132","author":"Zhang","year":"2019","journal-title":"Lung Cancer"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3390\/cancers13030415","article-title":"Primary pulmonary B-cell lymphoma: a review and update","volume":"13","author":"Sanguedolce","year":"2021","journal-title":"Cancer"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1053\/j.semdp.2020.04.002","article-title":"Primary pulmonary B-cell lymphoma","volume":"37","author":"Kelemen","year":"2020","journal-title":"Semin Diagn Pathol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"8657","DOI":"10.1038\/s41598-019-45144-9","article-title":"Pulmonary MALT lymphoma has variable features on CT","volume":"9","author":"Deng","year":"2019","journal-title":"Sci Rep"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"108339","DOI":"10.1016\/j.rmed.2025.108339","article-title":"Pulmonary mucosa-associated lymphoid tissue lymphoma (MALToma): clinico-radiologic features, diagnosis, and outcomes","volume":"248","author":"Tzilas","year":"2025","journal-title":"Respir Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1378\/chest.07-1956","article-title":"Marginal zone B-cell lymphoma of bronchus-associated lymphoid tissue: imaging findings in 21 patients","volume":"133","author":"Bae","year":"2008","journal-title":"Chest"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1007\/s11547-019-01091-z","article-title":"Primary pulmonary lymphoma: imaging findings in 30 cases","volume":"124","author":"Cozzi","year":"2019","journal-title":"Radiol Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1183\/13993003.01701-2015","article-title":"Pulmonary mucosa-associated lymphoid tissue lymphoma revisited","volume":"47","author":"Borie","year":"2016","journal-title":"Eur Respir J"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/jco.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.21037\/qims-21-255","article-title":"Diagnosis of diffuse parenchymal lung diseases using transbronchial cryobiopsy guided by endobronchial ultrasound compared to clinicoradiological diagnosis","volume":"12","author":"Li","year":"2022","journal-title":"Quant Imaging Med Surg"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s43168-025-00417-y","article-title":"A comparative study between transbronchial cryobiopsy vs forceps biopsy in patients with interstitial lung diseases guided by fluoroscope","volume":"19","author":"Elkomy","year":"2025","journal-title":"Egypt J Bronchol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/LBR.0000000000000566","article-title":"Radial Endobronchial ultrasound-guided Transbronchial Cryobiopsy","volume":"26","author":"Abdelghani","year":"2019","journal-title":"J Bronchology Interventional Pulmonol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1596730","DOI":"10.3389\/fmed.2025.1596730","article-title":"Pulmonary MALT lymphoma diagnosed with transbronchial lung cryobiopsy after unsuccessful transbronchial lung biopsy: a case report","volume":"12","author":"Tsukada","year":"2025","journal-title":"Front Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"00260","DOI":"10.1183\/23120541.00260-2019","article-title":"Transbronchial cryobiopsy: an effective tool in the diagnosis of lymphoproliferative disorders of the lung","volume":"6","author":"Bianchi","year":"2020","journal-title":"ERJ Open Res"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.21037\/jtd.2018.10.116","article-title":"The value of using radial endobronchial ultrasound to guide transbronchial lung cryobiopsy","volume":"11","author":"Gupta","year":"2019","journal-title":"J Thorac Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14010176","article-title":"Recent advances in the genetic of MALT lymphomas","volume":"14","author":"Rodr\u00edguez-Sevilla","year":"2021","journal-title":"Cancers (Basel)"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1053\/j.semnuclmed.2022.11.001","article-title":"PET\/CT in non-Hodgkin lymphoma: an update","volume":"53","author":"Zanoni","year":"2023","journal-title":"Semin Nucl Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1466859","DOI":"10.3389\/fimmu.2024.1466859","article-title":"Characteristics, efficacy, and prognosis analysis of newly diagnosed marginal zone lymphoma","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1471-2407-14-153","article-title":"Ki-67 is a valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes: evidence from a systematic meta-analysis","volume":"14","author":"He","year":"2014","journal-title":"BMC Cancer"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1182\/bloodadvances.2022007772","article-title":"Predictors of survival in patients with MALT lymphoma: a retrospective, case-control study","volume":"7","author":"Qi","year":"2023","journal-title":"Blood Adv"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1108837","DOI":"10.3389\/fonc.2023.1108837","article-title":"Multicolor flow cytometric assessment of Ki67 expression and its diagnostic value in mature B-cell neoplasms","volume":"13","author":"Mao","year":"2023","journal-title":"Front Oncol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s12185-014-1694-8","article-title":"Rituximab monotherapy as a first-line treatment for pulmonary mucosa-associated lymphoid tissue lymphoma","volume":"101","author":"Okamura","year":"2015","journal-title":"Int J Hematol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"20407","DOI":"10.1038\/s41598-025-07413-8","article-title":"Risk and clinical implications of histological transformation in extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a population-based analysis","volume":"15","author":"He","year":"2025","journal-title":"Sci Rep"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1719542\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T06:45:08Z","timestamp":1766040308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1719542\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":25,"alternative-id":["10.3389\/fmed.2025.1719542"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1719542","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"article-number":"1719542"}}